The novel approach of the medication represents a major breakthrough in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide094700.59bloggers.com/42362970/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment